Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
After reconstitution: Store at 28 C , protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling
Start with one or two changes today , your body (and future self) will thank you
A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation
Pfizer provides update on oral GLP-1 receptor agonist danuglipron
Eli Lilly - Manufacturing Investment (February 2026): Eli Lilly reported $1.5 billion pre-launch inventory for orforglipron and announced new manufacturing facilities as part of $27 billion investment drive [4]
